It also remains unclear how weight loss observed in these randomized controlled trials will generalize to real-world populations, said Nick Stucky, MD, PhD, vice president of Truveta Research, practicing infectious diseases physician at Providence Portland Medical Center, and an author on the paper
Phelan breaks down everything you need to know about this transformative procedure, which is designed to contour and redefine your midsection and beyond
But its not just about availability, either
The trial design included a dose-response evaluation to determine optimal dosing
Alexander GM, Schwartzman RJ, Nukes TA, Grothusen JR, Hooker MD
Belimumab was the first BAFF-inhibitor studied in MG but was not found to have benefit relative to placebo in a phase 2 trial